It also addresses the FDA’s communications with the applicant, the retention of records that assistance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer ownership of an SE report back to a completely new applicant and electronic submission on the SE report and